MultiOmyx: High-Order Multiplexing Methodology

NeoGenomics introduces MultiOmyx, a proprietary, multiplexing methodology that enables analysis of dozens of proteins and DNA biomarkers in a single tissue section. Instead of being able to study one or two disease markers at a time, MultiOmyx studies up to 60 biomarkers in a single tumor slice. It also uncovers the relationship between markers which could yield new insights and a more complete picture of tumor behavior.

The Key Benefits of MultiOmyx Include:

Learn More

Download a digital version of our MultiOmyx Poster: